期刊中文名:病理學ISSN:0031-2983E-ISSN:1591-951X
該雜志國(guo)際(ji)簡稱(cheng):PATHOLOGICA,是(shi)由出(chu)版(ban)商(shang)Pacini Editore SpA出(chu)版(ban)的(de)一本(ben)(ben)致(zhi)力于發布--研(yan)究新(xin)成(cheng)果(guo)的(de)的(de)專業學術期刊(kan)。主要(yao)發表刊(kan)登有(you)創見的(de)學術論(lun)文文章、行(xing)業最(zui)新(xin)科(ke)研(yan)成(cheng)果(guo),扼要(yao)報道階(jie)段性研(yan)究成(cheng)果(guo)和重要(yao)研(yan)究工作的(de)最(zui)新(xin)進展(zhan),選載對學科(ke)發展(zhan)起(qi)指導作用的(de)綜述與(yu)專論(lun),促進學術發展(zhan),為廣(guang)大(da)讀者服務(wu)。該刊(kan)是(shi)一本(ben)(ben)國(guo)際(ji)優秀雜志,在(zai)國(guo)際(ji)上有(you)很(hen)高(gao)的(de)學術影響力。
《Pathologica》是一本以(yi)(yi)English為(wei)(wei)(wei)主的(de)(de)(de)開放獲取國際優秀期刊,中(zhong)文名稱病理(li)學,本刊主要出版、報道領域(yu)(yu)的(de)(de)(de)研(yan)究動態(tai)以(yi)(yi)及在該領域(yu)(yu)取得(de)(de)的(de)(de)(de)各(ge)方(fang)面(mian)的(de)(de)(de)經驗和科(ke)研(yan)成果(guo),介紹該領域(yu)(yu)有關(guan)本專業(ye)的(de)(de)(de)最(zui)新進展(zhan)(zhan),探討行業(ye)發(fa)展(zhan)(zhan)的(de)(de)(de)思路和方(fang)法,以(yi)(yi)促進學術信息交流,提高行業(ye)發(fa)展(zhan)(zhan)。該刊已被國際權威數(shu)據(ju)庫SCIE收錄,為(wei)(wei)(wei)該領域(yu)(yu)相關(guan)學科(ke)的(de)(de)(de)發(fa)展(zhan)(zhan)起到了(le)良(liang)好(hao)的(de)(de)(de)推動作用,也(ye)得(de)(de)到了(le)本專業(ye)人員(yuan)的(de)(de)(de)廣泛認可。該刊最(zui)新影響因子為(wei)(wei)(wei)4.4,最(zui)新CiteScore 指數(shu)為(wei)(wei)(wei)5.9。
Pathology is an international academic journal dedicated to the field of pathology, publishing original research, review articles, and case reports on various branches of pathology. The content of this magazine not only covers traditional histopathology, cell pathology, and molecular pathology, but also includes emerging research fields such as digital pathology and translational pathology. The magazine aims to provide a platform for pathologists, clinical doctors, and related researchers to exchange the latest research findings and clinical experiences.
The editorial committee of the journal is composed of renowned pathologists from around the world, who ensure that the published articles have high academic standards and clinical relevance. It screens manuscripts through a peer review process to ensure the quality and scientific validity of the research. In addition, the journal also pays special attention to the progress of pathological diagnosis and its application in disease management, committed to promoting the role of pathology in improving patient care. Its readership is broad, including pathologists, pathology residents, clinical doctors, researchers, and medical students. By publishing cutting-edge research and in-depth reviews, this journal provides readers with valuable educational resources and professional knowledge, helping them maintain an understanding of the latest developments in the field of pathology.
按JIF指標學科分(fen)區(qu) |
學科:PATHOLOGY
收錄子集:ESCI
分區:Q1
排名:14 / 88
百分位:
84.7% |
按JCI指標學科分區 |
學科:PATHOLOGY
收錄子集:ESCI
分區:Q2
排名:36 / 88
百分位:
59.66% |
JCR分區:JCR分(fen)(fen)(fen)(fen)區(qu)來自科(ke)睿(rui)唯安公(gong)司,JCR是一個(ge)(ge)獨特的(de)多學科(ke)期(qi)刊(kan)評價(jia)工具,為唯一提供(gong)基(ji)于(yu)引(yin)文(wen)數(shu)(shu)據的(de)統計(ji)信息的(de)期(qi)刊(kan)評價(jia)資源。每(mei)年(nian)發布的(de)JCR分(fen)(fen)(fen)(fen)區(qu),設置了(le)254個(ge)(ge)具體學科(ke)。JCR分(fen)(fen)(fen)(fen)區(qu)根據每(mei)個(ge)(ge)學科(ke)分(fen)(fen)(fen)(fen)類按照期(qi)刊(kan)當(dang)年(nian)的(de)影(ying)響(xiang)因子高低(di)將期(qi)刊(kan)平(ping)均(jun)分(fen)(fen)(fen)(fen)為4個(ge)(ge)區(qu),分(fen)(fen)(fen)(fen)別為Q1、Q2、Q3和Q4,各占(zhan)25%。JCR分(fen)(fen)(fen)(fen)區(qu)中(zhong)期(qi)刊(kan)的(de)數(shu)(shu)量(liang)是均(jun)勻分(fen)(fen)(fen)(fen)為四(si)個(ge)(ge)部分(fen)(fen)(fen)(fen)的(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Pathology and Forensic Medicine | Q1 | 42 / 208 |
80% |
該(gai)(gai)雜(za)志(zhi)是(shi)一(yi)本國際(ji)優秀雜(za)志(zhi),在國際(ji)上(shang)有(you)較高(gao)(gao)的學術(shu)影響(xiang)力(li),行業(ye)關注度(du)很高(gao)(gao),已(yi)被(bei)國際(ji)權威數據庫(ku)SCIE收錄,該(gai)(gai)雜(za)志(zhi)在綜合專(zhuan)業(ye)領(ling)域專(zhuan)業(ye)度(du)認可很高(gao)(gao),對稿(gao)(gao)件內容的創新(xin)性和學術(shu)性要求(qiu)很高(gao)(gao),作(zuo)為一(yi)本國際(ji)優秀雜(za)志(zhi),一(yi)般投稿(gao)(gao)過(guo)審(shen)(shen)時間都較長(chang),投稿(gao)(gao)過(guo)審(shen)(shen)時間平(ping)均 ,如果(guo)想(xiang)投稿(gao)(gao)該(gai)(gai)刊要做好時間安排。版面費不(bu)祥。該(gai)(gai)雜(za)志(zhi)近(jin)兩年未被(bei)列入預(yu)警(jing)名單,建議您(nin)投稿(gao)(gao)。如您(nin)想(xiang)了解更多投稿(gao)(gao)政策(ce)及投稿(gao)(gao)方案,請(qing)咨(zi)詢客(ke)服。
若(ruo)用戶需要出版服務,請(qing)聯系出版商。